Navigation Links
Selection of Standards for Bio-Plex Cytokine Assays, Rev A

. This practice allows the flexibility to remove standard points with erroneous results due to errors in assay preparation.

2. Choose standards evenly distributed across the entire range of concentrations.
As noted earlier, the response of a Bio-Plex assay is nonlinear; there is a flattening of the response near zero and at the high end of the curve with a linear portion in the middle as shown in Figure 2. Due to the nature of this response, the chosen standards concentrations should be evenly distributed across the entire range (Nix and Wild 2001). The regression routine will then yield the most accurate representation of the assay response.

3. Choose a 5PL regression routine.
When conditions are optimal, the upper and lower portions of the curve are symmetrical, and the 4PL logistic routine is appropriate. In reality, many conditions, such as a high-dose hook effect and inadequate washing, can cause asymmetry in the curve (Nix and Wild 2001). The 5PL regression contains an additional parameter to accommodate asymmetry in the curve, and thus is the more robust type of logistic regression for Bio-Plex assays.

4. Prepare standards using serial dilutions.
When selecting the range of a custom set of standards, determine the lowest and highest desired concentrations, then determine what dilution series should be used to yield a total of 8 points within the range. For example, if the low and high desired values are 5 and 10,000 pg/ml respectively, a threefold dilution series would yield 8 points (10,000, 3,333, 1,111, 370, 123.4, 41.1, 13.7, and 4.6). A dilution series is simple to prepare and less prone to errors compared to preparation of individual concentrations.
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8

Related biology technology :

1. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
2. Plasmid Miniprep Kit Selection
3. Universal Guide to DNA Standards
4. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
5. Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A
6. Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A
7. Application of the Bio-Plex Cell Lysis Kit in Western Blot Analysis of Phosphoproteins, Rev A
8. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
9. Feasibility of Multiplexing Bio-Plex Total Target and Phosphoprotein Assays
10. Simultaneous Detection of 8 Cytokines in Mouse or Human Sera
11. The Gradient Feature: Use in Optimization of Allelic Discrimination Assays, Rev B
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Selection Standards for Bio Plex Cytokine Assays Rev

(Date:7/24/2008)...RA, Calif., July 24 /- Cohe...Company will release its financial,results after t... its third,fiscal quarter 2008 results scheduled f...be broadcast live over the Internet and can be acc.../ or http://www.earnings.com .,For those who are...
(Date:7/24/2008)...nt Increase in Product Sales Driven by Robust MRSA...irstCall/ -- Cepheid (Nasdaq:,CPHD) today reported...illion, an increase of 55% over the second quarter....13) per share, which compares to revenue of,$27.2...) per share, in the,second quarter of fiscal 2007....
(Date:7/24/2008)... Calif., July 24 /- InterMu...will release second quarter 2008,financial results...1, 2008,at 4:00 p.m. Eastern time. A live conferen... 4:30 p.m. Eastern time that same day., To access... or,706-634-0154 (international), conference ID# 5...
(Date:7/24/2008)...LLE, Minn., July 24 /- Roch...nounce quarterly results after,financial markets c...hen,hold a quarterly conference call to discuss it.... central daylight time (5:00 p.m. eastern time).,...an be accessed at,Rochester Medical,s website at ...
Breaking Biology Technology:Cepheid Reports Second Quarter Revenue of $42.1 Million 2Cepheid Reports Second Quarter Revenue of $42.1 Million 3Cepheid Reports Second Quarter Revenue of $42.1 Million 4Cepheid Reports Second Quarter Revenue of $42.1 Million 5Cepheid Reports Second Quarter Revenue of $42.1 Million 6Cepheid Reports Second Quarter Revenue of $42.1 Million 7Cepheid Reports Second Quarter Revenue of $42.1 Million 8Cepheid Reports Second Quarter Revenue of $42.1 Million 9Cepheid Reports Second Quarter Revenue of $42.1 Million 10Cepheid Reports Second Quarter Revenue of $42.1 Million 11Cepheid Reports Second Quarter Revenue of $42.1 Million 12Cepheid Reports Second Quarter Revenue of $42.1 Million 13InterMune to Release Second Quarter 2008 Financial Results and Provide Business Update on July 31 2Rochester Medical Announces Third Quarter 2008 Earnings Conference Call July 31, 2008 2
... As many as 1,000 people are expected to gather he...ical ways to protect the nation,s food supply. , ,...m , will draw public and private sector representa... according to David Duecker, who, with the Wiscons...vent. , ,"There has been nothing else like this in...
...s . -- GE Healthcare will collaborate with the ...ng GE Healthcare,s cellular imaging system, the IN...entral nervous system and neurodegenerative diseas...ompany announced on Thursday. , ,In addition, the ...p new software tools that will help speed disease ...
...ompanies regularly and eagerly await responses fro...l trials involving investigational products, submi... and other submissions and applications. But a dif...s much less welcome. , ,Warning letters provide wr...nt regulatory violations involving drugs, biologic...
...ngle word better describes today,s go-it-alone eco...ench-derived noun has a certain cachet that is app... , ,In today,s bootstrap economy, mayors of cities...ies and state-sponsored extension programs are rea...n their quests to be successful and create jobs. ,...
Other Biology Technology:Milwaukee to host inaugural Great Lakes Agro-Security Symposium 2Milwaukee to host inaugural Great Lakes Agro-Security Symposium 3It's in the mail -- Responding to an FDA warning letter 2It's in the mail -- Responding to an FDA warning letter 3It's in the mail -- Responding to an FDA warning letter 4Beware -- Use of the word 'entrepreneur' can put you in a legal mess 2Beware -- Use of the word 'entrepreneur' can put you in a legal mess 3Beware -- Use of the word 'entrepreneur' can put you in a legal mess 4Beware -- Use of the word 'entrepreneur' can put you in a legal mess 5
(Date:7/25/2008)...ectancy for patients with human immunodeficiency v...ce the late 1990s thanks to advancements in antire...University of Alabama at Birmingham (UAB) and Simo.... , Improved survival has led to a nearly 40 per... study participants in Europe and North America, b...
(Date:7/25/2008)...cialists from 22 countries are sharing the latest ...as mustard, radish, or rapeseed, to manage soil-bo...ation. ," Brassica plants naturally release com...lly isothiocyanates (ITCs), which most people woul...seradish," says CSIRO,s Dr John Kirkegaard. , "W...
(Date:7/24/2008)...emand for bio-fuels and hydro-electricity due to h...eats today to the preservation of precious wetland... areas for agriculture, energy crop plantations an...convert wetlands is vital to avoid destroying ecos...to humanity, including safe, steady local water su...
(Date:7/24/2008)... scientists have found black smoker vents farther ...r of five vents one towering nearly four stories ...issolved sulfide minerals that solidify when vent ... the years, accumulated around the vent field in w...e deposits ever found on the seafloor, according t...
Breaking Biology News(10 mins):Anti-HIV therapy boosts life expectancy more than 13 years 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 3Scientists break record by finding northernmost hydrothermal vent field 2Scientists break record by finding northernmost hydrothermal vent field 3ChanTest Launches Redesigned Web Site 5877 1ChanTest Launches Redesigned Web Site 5877 2OncoGenex to present at the Needham 26 Company 7th Annual Biotechnology 26 Medical Technology Conference 5874 1OncoGenex to present at the Needham 26 Company 7th Annual Biotechnology 26 Medical Technology Conference 5874 2OncoGenex to present at the Needham 26 Company 7th Annual Biotechnology 26 Medical Technology Conference 5874 3Women worrying about cancer are more likely to experience sleep disturbances 21286 1Women worrying about cancer are more likely to experience sleep disturbances 21286 2More marital happiness 3D less sleep complaints 21284 1More marital happiness 3D less sleep complaints 21284 2
...udy from Karolinska Institutet in Stockholm shows ...ivated in regular cycle training. The study also r... may be due to the ability in some people to activ... published May 2 in FASEB Journal. , It is common ... and that regular physical activity brings health,...
... of approximately 41,000-year-old human remains fo...ecome regionally mobile earlier than scientists on...Université Bordeaux 1 in France, Max Planck Instit...ouis, conclude that the human femur fragment found...comes from a Neandertal, based on its shape and mi...
...al lock and key mechanism that allows the final st... has been identified by a University of California...arch that promises to lead to a new way to halt tu..., The research team led by Judith Varner, Ph.D., A...r of the Rebecca and John Moores UCSD Cancer Cente...
... of the tsunami that killed over a quarter of a mi...mber, 2004, slowly disappear from the media, but t...emories of those who are directly involved. In the...ans alike are trying to investigate how the number...mportant, how such severe damage can be avoided if...
Other Biology News:Neandertal femur suggests competition with hyenas and a shift in landscape use 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 3Could better mangrove habitats have spared lives in the 2004 tsunami? 2
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926
Mouse monoclonal antibody raised against a partial recombinant FBXO11. NCBI Entrez Gene ID = FBXO11
Mouse polyclonal antibody raised against a partial recombinant COASY. NCBI Entrez Gene ID = 80347
MAb to Catenin beta, N-terminal (exon 2) Catenin, beta, N-terminal (exon 2)
Biology Products: